Midwest Professional Planners, Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Midwest Professional Planners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $52,671 - $61,276	-150 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $284 - $344	-1 Reduced 0.66%	150 $52,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $58,110 - $72,455	-184 Reduced 54.93%	151 $52,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $120,141 - $157,433	335	335 $126,000

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.